{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T04:57:24Z","timestamp":1794373044809,"version":"4.9.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","award":["01GM1904A"],"award-info":[{"award-number":["01GM1904A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","award":["01GM2204A"],"award-info":[{"award-number":["01GM2204A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 DK131033"],"award-info":[{"award-number":["R01 DK131033"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["5T35DK104689"],"award-info":[{"award-number":["5T35DK104689"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jhepr.2026.101902","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:14:04Z","timestamp":1780013644000},"page":"101902","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genetic testing in liver diseases: Clinical applications"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1383-7662","authenticated-orcid":false,"given":"Verena","family":"Keitel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7364-4112","authenticated-orcid":false,"given":"Anne","family":"Mentzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7634-5134","authenticated-orcid":false,"given":"Carola","family":"Dr\u00f6ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2099-4212","authenticated-orcid":false,"given":"Silvia","family":"Vilarinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7789","key":"10.1016\/j.jhepr.2026.101902_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41586-019-1879-7","article-title":"A brief history of human disease genetics","volume":"577","author":"Claussnitzer","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jhepr.2026.101902_bib2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.31887\/DCNS.2016.18.3\/jkrier","article-title":"Genomic sequencing in clinical practice: applications, challenges, and opportunities","volume":"18","author":"Krier","year":"2016","journal-title":"Dialogues Clin Neurosci"},{"issue":"1","key":"10.1016\/j.jhepr.2026.101902_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/jhg.2013.114","article-title":"The promise of whole-exome sequencing in medical genetics","volume":"59","author":"Rabbani","year":"2014","journal-title":"J Hum Genet"},{"issue":"45","key":"10.1016\/j.jhepr.2026.101902_bib4","doi-asserted-by":"crossref","first-page":"19096","DOI":"10.1073\/pnas.0910672106","article-title":"Genetic diagnosis by whole exome capture and massively parallel DNA sequencing","volume":"106","author":"Choi","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhepr.2026.101902_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2025.105043","article-title":"Diagnostic yield of whole exome sequencing in a cohort of 825 patients","volume":"78","author":"Andersen","year":"2025","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.jhepr.2026.101902_bib6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41525-018-0053-8","article-title":"Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases","volume":"3","author":"Clark","year":"2018","journal-title":"NPJ Genom Med"},{"issue":"2S1","key":"10.1016\/j.jhepr.2026.101902_bib7","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1016\/j.ajt.2025.01.022","article-title":"OPTN\/SRTR 2023 annual data report: liver","volume":"25","author":"Kwong","year":"2025","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.jhepr.2026.101902_bib8","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jhep.2019.01.036","article-title":"Clinical utility of genomic analysis in adults with idiopathic liver disease","volume":"70","author":"Hakim","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.101902_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104747","article-title":"Advancing diagnosis and management of liver disease in adults through exome sequencing","volume":"95","author":"Zheng","year":"2023","journal-title":"EBioMedicine"},{"issue":"17","key":"10.1016\/j.jhepr.2026.101902_bib10","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1073\/pnas.1418631112","article-title":"Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants","volume":"112","author":"Belkadi","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.jhepr.2026.101902_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.2148","article-title":"The current benefit of genome sequencing compared to exome sequencing in patients with developmental or epileptic encephalopathies","volume":"11","author":"Grether","year":"2023","journal-title":"Mol Genet Genomic Med"},{"issue":"1","key":"10.1016\/j.jhepr.2026.101902_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-21421-8","article-title":"Improved genomic characterization of a clinically heterogeneous pediatric cohort with WGS vs. WES","volume":"15","author":"Brashear","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jhepr.2026.101902_bib13","article-title":"Challenges in the diagnosis and treatment of genetic cholestasis in adults","volume":"8","author":"Thompson","year":"2026","journal-title":"JHEP Rep"},{"issue":"4","key":"10.1016\/j.jhepr.2026.101902_bib14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cld.2018.06.003","article-title":"Progressive familial intrahepatic cholestasis","volume":"22","author":"Bull","year":"2018","journal-title":"Clin Liver Dis"},{"issue":"6","key":"10.1016\/j.jhepr.2026.101902_bib15","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/hep.32437","article-title":"Cholestatic liver diseases of genetic etiology: advances and controversies","volume":"75","author":"Ibrahim","year":"2022","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.jhepr.2026.101902_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2021.104317","article-title":"The spectrum of Progressive Familial Intrahepatic Cholestasis diseases: update on pathophysiology and emerging treatments","volume":"64","author":"Felzen","year":"2021","journal-title":"Eur J Med Genet"},{"issue":"10","key":"10.1016\/j.jhepr.2026.101902_bib17","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1002\/hep4.2051","article-title":"Clinical phenotype of adult-onset liver disease in patients with variants in ABCB4, ABCB11, and ATP8B1","volume":"6","author":"Nayagam","year":"2022","journal-title":"Hepatol Commun"},{"issue":"6","key":"10.1016\/j.jhepr.2026.101902_bib18","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jhep.2017.07.004","article-title":"Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants","volume":"67","author":"Dr\u00f6ge","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.101902_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2025.105916","article-title":"Idiopathic cholestasis in adults: genetics as another lens for liver pathologists","volume":"165","author":"Tamburro","year":"2025","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.jhepr.2026.101902_bib20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ng0398-219","article-title":"A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis","volume":"18","author":"Bull","year":"1998","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.jhepr.2026.101902_bib21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/3034","article-title":"A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis","volume":"20","author":"Strautnieks","year":"1998","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.jhepr.2026.101902_bib22","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.95.1.282","article-title":"Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis","volume":"95","author":"de Vree","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.jhepr.2026.101902_bib23","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/liv.15185","article-title":"Clinical exome sequencing for diagnosing severe cryptogenic liver disease in adults: a case series","volume":"42","author":"Pelusi","year":"2022","journal-title":"Liver Int"},{"issue":"8","key":"10.1016\/j.jhepr.2026.101902_bib24","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00535-017-1423-1","article-title":"Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing","volume":"53","author":"Vitale","year":"2018","journal-title":"J Gastroenterol"},{"issue":"5","key":"10.1016\/j.jhepr.2026.101902_bib25","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/hep4.1149","article-title":"Phenotypic spectrum and diagnostic pitfalls of ABCB4 deficiency depending on age of onset","volume":"2","author":"Schatz","year":"2018","journal-title":"Hepatol Commun"},{"issue":"3","key":"10.1016\/j.jhepr.2026.101902_bib26","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jhep.2020.04.036","article-title":"Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults","volume":"73","author":"St\u00e4ttermayer","year":"2020","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2026.101902_bib27","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0030-1253223","article-title":"The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects","volume":"30","author":"Davit-Spraul","year":"2010","journal-title":"Semin Liver Dis"},{"issue":"4","key":"10.1016\/j.jhepr.2026.101902_bib28","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/hep.22485","article-title":"A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults","volume":"48","author":"Gotthardt","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jhepr.2026.101902_bib29","article-title":"Low-phospholipid-associated cholelithiasis syndrome: prevalence, clinical features, and comorbidities","volume":"3","author":"Dong","year":"2021","journal-title":"JHEP Rep"},{"issue":"3","key":"10.1016\/j.jhepr.2026.101902_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/1753495X241263441","article-title":"Genetic issues in ICP","volume":"17","author":"Z\u00f6llner","year":"2024","journal-title":"Obstet Med"},{"issue":"2","key":"10.1016\/j.jhepr.2026.101902_bib31","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1053\/j.gastro.2006.05.003","article-title":"Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy","volume":"131","author":"Keitel","year":"2006","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.jhepr.2026.101902_bib32","article-title":"Outcomes of 38 patients with PFIC3: impact of genotype and of response to ursodeoxycholic acid therapy","volume":"5","author":"Gonzales","year":"2023","journal-title":"JHEP Rep"},{"issue":"4","key":"10.1016\/j.jhepr.2026.101902_bib33","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/gut.2008.159541","article-title":"Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy","volume":"58","author":"Dixon","year":"2009","journal-title":"Gut"},{"issue":"11\u201312","key":"10.1016\/j.jhepr.2026.101902_bib34","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1111\/apt.16118","article-title":"Review article: liver disease in adults with variants in the cholestasis-related genes ABCB11, ABCB4 and ATP8B1","volume":"52","author":"Nayagam","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.jhepr.2026.101902_bib35","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/ng.2918","article-title":"Mutations in TJP2 cause progressive cholestatic liver disease","volume":"46","author":"Sambrotta","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhepr.2026.101902_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10713","article-title":"Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis","volume":"7","author":"Gomez-Ospina","year":"2016","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jhepr.2026.101902_bib37","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.28779","article-title":"MYO5B mutations cause cholestasis with normal serum gamma-glutamyl transferase activity in children without microvillous inclusion disease","volume":"65","author":"Gonzales","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.101902_bib38","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jpeds.2021.09.019","article-title":"KIF12 variants and disturbed hepatocyte polarity in children with a phenotypic spectrum of cholestatic liver disease","volume":"240","author":"Stalke","year":"2022","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.jhepr.2026.101902_bib39","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/s41436-018-0288-x","article-title":"Identification of novel loci for pediatric cholestatic liver disease defined by KIF12, PPM1F, USP53, LSR, and WDR83OS pathogenic variants","volume":"21","author":"Maddirevula","year":"2019","journal-title":"Genet Med"},{"issue":"8","key":"10.1016\/j.jhepr.2026.101902_bib40","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/jmedgenet-2019-106706","article-title":"Biallelic loss-of-function ZFYVE19 mutations are associated with congenital hepatic fibrosis, sclerosing cholangiopathy and high-GGT cholestasis","volume":"58","author":"Luan","year":"2021","journal-title":"J Med Genet"},{"issue":"11","key":"10.1016\/j.jhepr.2026.101902_bib41","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114563","article-title":"A homozygous R148W mutation in Semaphorin 7A causes progressive familial intrahepatic cholestasis","volume":"13","author":"Pan","year":"2021","journal-title":"EMBO Mol Med"},{"issue":"1","key":"10.1016\/j.jhepr.2026.101902_bib42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1053\/j.gastro.2021.03.026","article-title":"Deleterious variants in ABCC12 are detected in idiopathic chronic cholestasis and cause intrahepatic bile duct loss in model organisms","volume":"161","author":"Pham","year":"2021","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jhepr.2026.101902_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101800","article-title":"Intrahepatic cholestasis of pregnancy in conjunction with a frameshift deletion in FGFR4","volume":"46","author":"Batool","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhepr.2026.101902_bib44","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jpeds.2020.01.064","article-title":"Biallelic mutations in the LSR gene cause a novel type of infantile intrahepatic cholestasis","volume":"221","author":"Uehara","year":"2020","journal-title":"J Pediatr"},{"key":"10.1016\/j.jhepr.2026.101902_bib45","article-title":"Liver disease reveals KIF12 as a critical regulator of mitochondria, lysosome and cilia localization","author":"Seth","year":"2026","journal-title":"bioRxiv"},{"issue":"10","key":"10.1016\/j.jhepr.2026.101902_bib46","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000812","article-title":"iPSC-based hepatic organoids reveal a heterozygous MYO5B variant as driver of intrahepatic cholestasis","volume":"9","author":"Sgodda","year":"2025","journal-title":"Hepatol Commun"},{"issue":"4","key":"10.1016\/j.jhepr.2026.101902_bib47","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1159\/000518203","article-title":"Common ABCB4 and ABCB11 genotypes are associated with idiopathic chronic cholestasis in adults","volume":"40","author":"J\u00fcngst","year":"2022","journal-title":"Dig Dis"},{"issue":"1","key":"10.1016\/j.jhepr.2026.101902_bib48","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3748\/wjg.14.38","article-title":"Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331T>C polymorphism in the bile salt export pump","volume":"14","author":"Meier","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jhepr.2026.101902_bib49","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s13023-022-02565-6","article-title":"A common variant in the hepatobiliary phospholipid transporter ABCB4 modulates liver injury in PBC but not in PSC: prospective analysis in 867 patients","volume":"17","author":"Kruk","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"10.1016\/j.jhepr.2026.101902_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2021.104292","article-title":"The genetic architecture of primary biliary cholangitis","volume":"64","author":"Gerussi","year":"2021","journal-title":"Eur J Med Genet"},{"issue":"3","key":"10.1016\/j.jhepr.2026.101902_bib51","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jhep.2021.04.055","article-title":"An international genome-wide meta-analysis of primary biliary cholangitis: novel risk loci and candidate drugs","volume":"75","author":"Cordell","year":"2021","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jhepr.2026.101902_bib52","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/j.gastro.2009.11.046","article-title":"Genome-wide association analysis in primary sclerosing cholangitis","volume":"138","author":"Karlsen","year":"2010","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jhepr.2026.101902_bib53","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.728","article-title":"Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci","volume":"43","author":"Melum","year":"2011","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.jhepr.2026.101902_bib54","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng.3745","article-title":"Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease","volume":"49","author":"Ji","year":"2017","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.jhepr.2026.101902_bib55","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1111\/liv.14662","article-title":"Carriers of ABCB4 gene variants show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinoma","volume":"40","author":"de Vries","year":"2020","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.jhepr.2026.101902_bib56","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"EASL clinical practice guidelines on sclerosing cholangitis","volume":"77","year":"2022","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2026.101902_bib57","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jhep.2024.04.006","article-title":"EASL Clinical Practice Guidelines on genetic cholestatic liver diseases","volume":"81","year":"2024","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.jhepr.2026.101902_bib58","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.157906","article-title":"Ethnic and sex differences in hepatic lipid content and related cardiometabolic parameters in lean individuals","volume":"7","author":"Petersen","year":"2022","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.jhepr.2026.101902_bib59","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41572-025-00599-1","article-title":"Metabolic dysfunction-associated steatotic liver disease in adults","volume":"11","author":"Huang","year":"2025","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.jhepr.2026.101902_bib60","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S2213-8587(24)00318-8","article-title":"Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment","volume":"13","author":"Stefan","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"10.1016\/j.jhepr.2026.101902_bib61","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/hep.32047","article-title":"Emerging role of genomic analysis in clinical evaluation of lean individuals with NAFLD","volume":"74","author":"Vilarinho","year":"2021","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jhepr.2026.101902_bib62","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jhep.2019.03.026","article-title":"Inherited non-alcoholic fatty liver disease and dyslipidemia due to monoallelic ABHD5 mutations","volume":"71","author":"Youssefian","year":"2019","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jhepr.2026.101902_bib63","article-title":"Genomic analysis of lean individuals with NAFLD identifies monogenic disorders in a prospective cohort study","volume":"5","author":"Zheng","year":"2023","journal-title":"JHEP Rep"},{"issue":"4","key":"10.1016\/j.jhepr.2026.101902_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27041933","article-title":"Genetic predisposition to MASLD: potential for therapeutic management","volume":"27","author":"Karapanagiotidi","year":"2026","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jhepr.2026.101902_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47737-w","article-title":"The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids","volume":"9","author":"Prill","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jhepr.2026.101902_bib66","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jhep.2014.02.030","article-title":"Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma","volume":"61","author":"Liu","year":"2014","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.jhepr.2026.101902_bib67","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/j.cell.2023.03.014","article-title":"Positive selection of somatically mutated clones identifies adaptive pathways in metabolic liver disease","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"},{"issue":"7779","key":"10.1016\/j.jhepr.2026.101902_bib68","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41586-019-1670-9","article-title":"Somatic mutations and clonal dynamics in healthy and cirrhotic human liver","volume":"574","author":"Brunner","year":"2019","journal-title":"Nature"},{"issue":"7881","key":"10.1016\/j.jhepr.2026.101902_bib69","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41586-021-03974-6","article-title":"Convergent somatic mutations in metabolism genes in chronic liver disease","volume":"598","author":"Ng","year":"2021","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.jhepr.2026.101902_bib70","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1056\/NEJMoa2117872","article-title":"Germline mutations in CIDEB and protection against liver disease","volume":"387","author":"Verweij","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jhepr.2026.101902_bib71","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/apt.17292","article-title":"Review article: the role of HSD17B13 on global epidemiology, natural history, pathogenesis and treatment of NAFLD","volume":"57","author":"Amangurbanova","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.jhepr.2026.101902_bib72","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.cell.2019.03.026","article-title":"Somatic mutations increase hepatic clonal fitness and regeneration in chronic liver disease","volume":"177","author":"Zhu","year":"2019","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jhepr.2026.101902_bib73","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11894-009-0082-7","article-title":"Cryptogenic cirrhosis: what are we missing?","volume":"12","author":"Caldwell","year":"2010","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.jhepr.2026.101902_bib74","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.humpath.2019.09.015","article-title":"Etiology of cirrhosis in the young","volume":"96","author":"Olave","year":"2020","journal-title":"Hum Pathol"},{"issue":"9","key":"10.1016\/j.jhepr.2026.101902_bib75","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.14309\/ajg.0000000000003244","article-title":"Celiac disease is common in adults with cryptogenic cirrhosis and responds favorably to gluten-free diet","volume":"120","author":"Pachisia","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jhepr.2026.101902_bib76","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jhep.2017.11.018","article-title":"Is cryptogenic cirrhosis different from NASH cirrhosis?","volume":"68","author":"Thuluvath","year":"2018","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.jhepr.2026.101902_bib77","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/j.jhep.2023.05.049","article-title":"Where does genetic testing fit in the diagnostic pathway of patients with cryptogenic cirrhosis?","volume":"79","author":"Nayagam","year":"2023","journal-title":"J Hepatol"},{"issue":"16","key":"10.1016\/j.jhepr.2026.101902_bib78","article-title":"Exome sequencing in adults with unexplained liver disease: diagnostic yield and clinical impact","volume":"15","author":"Moral","year":"2025","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"10.1016\/j.jhepr.2026.101902_bib79","article-title":"Clinical utility and genomic insights from whole exome and clinical exome sequencing in idiopathic liver disease","volume":"35","author":"Bozkurt","year":"2026","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.jhepr.2026.101902_bib80","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/hep.32364","article-title":"Genomic medicine for liver disease","volume":"76","author":"Zheng","year":"2022","journal-title":"Hepatology"},{"issue":"15","key":"10.1016\/j.jhepr.2026.101902_bib81","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMra1910234","article-title":"Alpha(1)-Antitrypsin deficiency","volume":"382","author":"Strnad","year":"2020","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jhepr.2026.101902_bib82","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.14309\/ajg.0000000000000315","article-title":"ACG clinical guideline: hereditary hemochromatosis","volume":"114","author":"Kowdley","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jhepr.2026.101902_bib83","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/MOG.0000000000001151","article-title":"Pathophysiology of cystic fibrosis-related liver disease","volume":"42","author":"Palmiotti","year":"2026","journal-title":"Curr Opin Gastroenterol"},{"issue":"5","key":"10.1016\/j.jhepr.2026.101902_bib84","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ajhg.2022.03.015","article-title":"Progressive liver, kidney, and heart degeneration in children and adults affected by TULP3 mutations","volume":"109","author":"Devane","year":"2022","journal-title":"Am J Hum Genet"},{"issue":"8","key":"10.1016\/j.jhepr.2026.101902_bib85","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/s41588-022-01120-0","article-title":"Loss of FOCAD, operating via the SKI messenger RNA surveillance pathway, causes a pediatric syndrome with liver cirrhosis","volume":"54","author":"Moreno Traspas","year":"2022","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.jhepr.2026.101902_bib86","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000462","article-title":"Liver disease and transplantation in telomere biology disorders: an international multicenter cohort","volume":"8","author":"Wang","year":"2024","journal-title":"Hepatol Commun"},{"issue":"8","key":"10.1016\/j.jhepr.2026.101902_bib87","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1080\/15476286.2015.1094596","article-title":"The molecular genetics of the telomere biology disorders","volume":"13","author":"Bertuch","year":"2016","journal-title":"RNA Biol"},{"issue":"3","key":"10.1016\/j.jhepr.2026.101902_bib88","first-page":"797","article-title":"Diagnosis and management of adult telomere biology disorders","volume":"111","author":"Franke","year":"2026","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.jhepr.2026.101902_bib89","article-title":"Letter to the Editor: 'Rare but relevant: genetic liver disease in the general medical setting'","volume":"26","author":"McCarron","year":"2026","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.jhepr.2026.101902_bib90","article-title":"Germline variants influence chronic liver disease progression through distinct pathways","author":"Vujkovic","year":"2025","journal-title":"medRxiv"},{"issue":"5","key":"10.1016\/j.jhepr.2026.101902_bib91","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41588-024-01720-y","article-title":"Integrative common and rare variant analyses provide insights into the genetic architecture of liver cirrhosis","volume":"56","author":"Ghouse","year":"2024","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.jhepr.2026.101902_bib92","article-title":"Alpha-1 antitrypsin Pi \u2217Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver disease","volume":"4","author":"Balcar","year":"2022","journal-title":"JHEP Rep"},{"issue":"6","key":"10.1016\/j.jhepr.2026.101902_bib93","article-title":"Hepatic decompensation is accelerated in patients with cirrhosis and alpha-1 antitrypsin Pi \u2217MZ genotype","volume":"4","author":"Chen","year":"2022","journal-title":"JHEP Rep"},{"issue":"8","key":"10.1016\/j.jhepr.2026.101902_bib94","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep4.1718","article-title":"Heterozygosity of the alpha 1-antitrypsin Pi\u2217Z allele and risk of liver disease","volume":"5","author":"Hakim","year":"2021","journal-title":"Hepatol Commun"},{"issue":"6","key":"10.1016\/j.jhepr.2026.101902_bib95","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/hep.30826","article-title":"Exome sequencing in clinical hepatology","volume":"70","author":"Vilarinho","year":"2019","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jhepr.2026.101902_bib96","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000408","article-title":"Genetics of liver disease in adults","volume":"8","author":"Konkwo","year":"2024","journal-title":"Hepatol Commun"},{"issue":"12","key":"10.1016\/j.jhepr.2026.101902_bib97","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1111\/liv.15732","article-title":"The genetics of portal hypertension: recent developments and the road ahead","volume":"43","author":"Shalaby","year":"2023","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.jhepr.2026.101902_bib98","doi-asserted-by":"crossref","first-page":"297","DOI":"10.5114\/ceh.2023.133107","article-title":"Porto-sinusoidal vascular disease: a new definition of an old clinical entity","volume":"9","author":"Barisic-Jaman","year":"2023","journal-title":"Clin Exp Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2026.101902_bib99","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/HEP.0000000000000973","article-title":"Genetic predisposition to porto-sinusoidal vascular disorder","volume":"83","author":"Ciriaci","year":"2026","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jhepr.2026.101902_bib100","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.jhep.2015.11.027","article-title":"A de novo mutation in KCNN3 associated with autosomal dominant idiopathic non-cirrhotic portal hypertension","volume":"64","author":"Koot","year":"2016","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.jhepr.2026.101902_bib101","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201745","article-title":"GIMAP5 maintains liver endothelial cell homeostasis and prevents portal hypertension","volume":"218","author":"Drzewiecki","year":"2021","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.jhepr.2026.101902_bib102","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jhep.2021.03.005","article-title":"A single cell gene expression atlas of 28 human livers","volume":"75","author":"Brancale","year":"2021","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2026.101902_bib103","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41590-023-01691-y","article-title":"GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway","volume":"25","author":"Park","year":"2024","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.jhepr.2026.101902_bib104","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.dld.2025.01.038","article-title":"Clinicopathological features of porto-sinusoidal vascular disorder with a novel GIMAP5 mutation in a pair of twin siblings","volume":"57","author":"Hu","year":"2025","journal-title":"Dig Liver Dis"},{"issue":"4","key":"10.1016\/j.jhepr.2026.101902_bib105","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.jhep.2023.03.030","article-title":"Hepatology Genome Rounds: an interdisciplinary approach to integrate genomic data into clinical practice","volume":"79","author":"Chung","year":"2023","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jhepr.2026.101902_bib106","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/jimd.12733","article-title":"Genetic aetiologies of acute liver failure","volume":"47","author":"Hegarty","year":"2024","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"10.1016\/j.jhepr.2026.101902_bib107","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.jhep.2014.06.038","article-title":"Individual exome analysis in diagnosis and management of paediatric liver failure of indeterminate aetiology","volume":"61","author":"Vilarinho","year":"2014","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jhepr.2026.101902_bib108","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/CEH.0000000000000019","article-title":"Challenges and opportunities for genomics education: insights from an institute of medicine roundtable activity","volume":"36","author":"Dougherty","year":"2016","journal-title":"J Contin Educ Health Prof"},{"issue":"9","key":"10.1016\/j.jhepr.2026.101902_bib109","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/MCG.0000000000000825","article-title":"Multidisciplinary management of hepatocellular carcinoma improves access to therapy and patient survival","volume":"51","author":"Agarwal","year":"2017","journal-title":"J Clin Gastroenterol"},{"issue":"8","key":"10.1016\/j.jhepr.2026.101902_bib110","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1053\/j.gastro.2017.02.040","article-title":"Association of provider specialty and multidisciplinary care with hepatocellular carcinoma treatment and mortality","volume":"152","author":"Serper","year":"2017","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jhepr.2026.101902_bib111","doi-asserted-by":"crossref","DOI":"10.5306\/wjco.v16.i4.100729","article-title":"Multidisciplinary tumor board is associated with improved survival in patients with hepatocellular carcinoma after liver transplantation","volume":"16","author":"Zhang","year":"2025","journal-title":"World J Clin Oncol"},{"issue":"3","key":"10.1016\/j.jhepr.2026.101902_bib112","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jhepr.2026.101902_bib113","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jhep.2021.01.045","article-title":"Diagnosis and management of secondary causes of steatohepatitis","volume":"74","author":"Liebe","year":"2021","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jhepr.2026.101902_bib114","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13023-019-1152-z","article-title":"Position statement on access to care in rare liver diseases: advancements of the European reference network (ERN) RARE-LIVER","volume":"14","author":"Bernts","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"10.1016\/j.jhepr.2026.101902_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110769","article-title":"A farnesoid X receptor T296I variant disrupts ligand-induced FXR activation and thus bile acid transport in progressive familial intrahepatic cholestasis","volume":"301","author":"Behrendt","year":"2025","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhepr.2026.101902_bib116","article-title":"Liver transcriptome sequencing contributes to the molecular diagnosis of genetic liver diseases","author":"Cheng","year":"2026","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jhepr.2026.101902_bib117","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s43681-021-00131-7","article-title":"The ethical issues of the application of artificial intelligence in healthcare: a systematic scoping review","volume":"2","author":"Karimian","year":"2022","journal-title":"AI and Ethics"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555926001734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555926001734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:18:30Z","timestamp":1790111910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555926001734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":117,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2589555926001734"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.101902","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic testing in liver diseases: Clinical applications","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.101902","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101902"}}